Infinitus Releases an Agentic AI Platform to Assist Pharmaceutical Companies With Direct-to-Consumer Tactics

Infinitus Systems, an agentic artificial intelligence startup focused on automating healthcare communications, is launching a new platform designed to help pharmaceutical companies strengthen and scale their direct-to-consumer (DTC) strategies. The expanded suite uses AI-powered agents to support patient engagement, streamline information flows, and resolve common barriers that prevent consumers from accessing or adhering to prescribed medications.

The company says its technology ensures that authoritative, manufacturer-verified information appears prominently in major search engines and digital touchpoints. This includes clear guidance on dosing, storage, side effects, affordability programs, and pharmacy fulfillment options — areas where patients often struggle to find reliable answers. By acting as an automated front door, the platform aims to close information gaps that can lead to confusion, treatment delays, or medication abandonment.

Infinitus notes that effective DTC communication requires pulling data from a fragmented healthcare ecosystem. Manufacturers often rely on input from providers, payers, pharmacies, and patients themselves, but every step introduces potential points of failure — from complex benefit designs to limited visibility into real-time pharmacy pricing. These challenges are especially significant as more pharmaceutical companies seek to establish direct relationships with consumers to support adherence and demonstrate value.

Infinitus CEO Ankit Jain told Fierce Healthcare that the momentum behind DTC models is unlikely to slow. He pointed to federal initiatives such as most-favored nation drug pricing policies and the TrumpRx program, which encourage manufacturers to engage more directly with patients. “We’re helping that manufacturer triage all the interactions that come into their contact centers by agentically answering them,” Jain said. “You decide which one is best for you, and our AI agents can do that or answer questions about the medication.”

Beyond responding to incoming inquiries, Infinitus’ system also supports proactive outreach. The platform can automatically contact patients who left prescriptions in their online carts, identifying barriers such as cost, authorization requirements, or confusion about instructions. It also offers 24/7 support through conversational AI agents and can escalate issues requiring clinical judgment to licensed professionals. Key concerns like pricing, pharmacy availability, and benefit eligibility are prioritized to reduce friction at critical decision points.

The company says real-time pricing intelligence will help patients secure the best available deals at the pharmacy counter, an increasingly important issue as out-of-pocket drug costs rise. Infinitus also emphasizes its ability to improve adherence by delivering educational materials, symptom-management resources, and tailored prompts that keep patients engaged throughout their treatment journey.

Jain said the Infinitus team has spent years working within the pharmaceutical ecosystem and sees today’s DTC push as only the beginning. “It is step one in that journey to really bring the best of AI and the best of humans together for a healthcare system,” he said, noting that agentic AI can dramatically reduce administrative burden while enabling more scalable, personalized communication.

As pharmaceutical companies accelerate their shift toward consumer-first models, Infinitus hopes its platform will serve as the connective tissue between manufacturers and patients — ensuring that critical information is accessible, interactions are timely, and adherence barriers are addressed before they interrupt care.

Infinitus Unveils a Next-Gen Agentic AI Platform for DTC Pharma Transformation

Infinitus has officially released a groundbreaking agentic AI platform engineered to support pharmaceutical companies in implementing advanced direct-to-consumer (DTC) tactics. As the healthcare industry rapidly shifts toward more personalized outreach, Infinitus is stepping in to ensure that pharma brands can build stronger, faster, and more compliant communication pathways with patients.

The new platform by Infinitus integrates automated decision-making, intelligent workflow management, and real-time content adaptation — all designed to elevate how pharmaceutical companies engage with consumers. Everyone solution delivered by Infinitus focuses on reducing communication gaps, improving medication awareness, and helping brands create more meaningful patient journeys.

How Infinitus Strengthens DTC Communication

Infinitus designed its agentic AI platform to address key challenges that pharma companies face when connecting directly with patients. Everyone feature in the system enables:

1. Intelligent Outreach Automation

Infinitus equips marketing and patient-support teams with adaptive communication workflows that adjust to patient behavior, preferences, and needs.

2. Compliance-Friendly Messaging

With strict industry regulations, Infinitus ensures that everyone automated message follows regulatory requirements and maintains accuracy across all channels.

3. Personalized DTC Experiences

Infinitus leverages patient insights and advanced analytics to craft communication that resonates on a personal level, increasing engagement and brand trust.